EGFR


The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands.
The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer.
  • ASP8273 EY2847

    ASP8273 is a small molecule, irreversible TKI inhibitor that inhibits the kinase activity of EGFR mutations including T790M, with limited activity against EGFR wild-type NSCLC. In the in vitro enzymatic and cell-based assays, ASP8273 were evaluated against EGFR mutantsand WT EGFR.

    More
  • EGF-816 EY2846

    EGF816 is a third-generation covalent EGFR inhibitor that has potent inhibitory activity against activating and resistant T790M mutants with low IC50 in various cellular assays.

    More
  • HM-71224 EY2845

    HM-71224 is an EGFR tyrosine kinase inhibitor.

    More
  • Erlotinib HCl EY0933

    Erlotinib HCl (OSI-744)是一种EGFR抑制剂,IC50为2 nM,对EGFR的选择性比c-Src或v-Abl高1000倍以上。

    More
  • Afatinib EY1739

    Afatinib (BIBW2992)是一种不可逆EGFR/HER2抑制剂,对EGFR(wt), EGFR(L858R), EGFR(L858R/T790M)和HER2均有抑制作用,IC50分别为0.5 nM,0.4 nM,10 nM和14 nM;用于Gefitinib抗性的突变型EGFR (L858R-T790M )时,活性增强100倍。

    More
  • ASP8273 EY2847

    ASP8273 is a small molecule, irreversible TKI inhibitor that inhibits the kinase activity of EGFR mutations including T790M, with limited activity against EGFR wild-type NSCLC. In the in vitro enzymatic and cell-based assays, ASP8273 were evaluated against EGFR mutantsand WT EGFR.

    More
  • EGF-816 EY2846

    EGF816 is a third-generation covalent EGFR inhibitor that has potent inhibitory activity against activating and resistant T790M mutants with low IC50 in various cellular assays.

    More
  • HM-71224 EY2845

    HM-71224 is an EGFR tyrosine kinase inhibitor.

    More
  • Erlotinib HCl EY0933

    Erlotinib HCl (OSI-744)是一种EGFR抑制剂,IC50为2 nM,对EGFR的选择性比c-Src或v-Abl高1000倍以上。

    More
  • Afatinib EY1739

    Afatinib (BIBW2992)是一种不可逆EGFR/HER2抑制剂,对EGFR(wt), EGFR(L858R), EGFR(L858R/T790M)和HER2均有抑制作用,IC50分别为0.5 nM,0.4 nM,10 nM和14 nM;用于Gefitinib抗性的突变型EGFR (L858R-T790M )时,活性增强100倍。

    More
  • ASP8273 EY2847

    ASP8273 is a small molecule, irreversible TKI inhibitor that inhibits the kinase activity of EGFR mutations including T790M, with limited activity against EGFR wild-type NSCLC. In the in vitro enzymatic and cell-based assays, ASP8273 were evaluated against EGFR mutantsand WT EGFR.

    More
  • EGF-816 EY2846

    EGF816 is a third-generation covalent EGFR inhibitor that has potent inhibitory activity against activating and resistant T790M mutants with low IC50 in various cellular assays.

    More
  • HM-71224 EY2845

    HM-71224 is an EGFR tyrosine kinase inhibitor.

    More
  • Erlotinib HCl EY0933

    Erlotinib HCl (OSI-744)是一种EGFR抑制剂,IC50为2 nM,对EGFR的选择性比c-Src或v-Abl高1000倍以上。

    More
  • Afatinib EY1739

    Afatinib (BIBW2992)是一种不可逆EGFR/HER2抑制剂,对EGFR(wt), EGFR(L858R), EGFR(L858R/T790M)和HER2均有抑制作用,IC50分别为0.5 nM,0.4 nM,10 nM和14 nM;用于Gefitinib抗性的突变型EGFR (L858R-T790M )时,活性增强100倍。

    More
  • Current page1, Total Pages7, Total Record31 First Prev 12345 Next Last Goto